Head and neck squamous cell carcinoma
Nature Reviews Disease Primers, 2020
2,075 citations recorded by the source corpus.
Head and neck squamous cell carcinomas (HNSCCs) originate from the mucosal epithelium in the oral cavity, pharynx and larynx, and are caused by viral infection or carcinogen exposure. This PrimeView provides an overview of HNSCC diagnosis, epidemiology, pathogenesis and treatment as well as patient quality of life.
Subfields: Oncology, Otorhinolaryngology, Surgery
View Paper: https://www.semanticscholar.org/paper/09aff431880ba0f377397157a4d675062ffd2aac
Citations in the corpus
- Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas – comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients (2023, background): “Head and neck cancer is one of the most immune-inflamed human tumors, but response rates to PD-1 checkpoint inhibition are modest (27) resulting in a persistently poor prognosis with fiveyear survival rates of 50-60% (8).”
- Type I conventional dendritic cells and CD8+ T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients (2024, background): “Besides some well-known risk factors, such as extensive consumption of tobacco and alcohol, the infection with HPV (primarily genotype 16) causes carcinogenesis in roughly 25% of HNSCC, particularly in the oropharynx (> 70%), hence representing a major leading factor for HNSCC development (2).”
- Comprehensive Transcriptome Analysis Reveals the Distinct Gene Expression Patterns of Tumor Microenvironment in HPV-Associated and HPV-Non Associated Tonsillar Squamous Cell Carcinoma (2023, background): “Head and neck squamous cell carcinomas (HNSCCs) have a high morbidity and mortality rate and rank as the sixth most common cancer globally, with approximately 900,000 new cases and more than 450,000 deaths in the last two years [1,2].”